Publications

Characterisation of Mobile Elements Carrying Metallo-Beta-Lactamase (MBL) Genes, blaIMP-1, blaIMP-14, blaSPM-1, blaVIM-2 from Latin American Medical Centres: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Toleman MA, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Dissemination of Metallo-Beta-Lactamases in Europe via a Tn5051-like Composite Transposon: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Toleman MA, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Wide Dissemination of SPM-Like-Metallo-Beta-Lactamase among Carbapenem-Resistant Pseudomonas aeruginosa Strains Isolated in Brazilian Hospitals, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Emergence and Dissemination of IMP-Like Metallo-Beta-Lactamase-Producing Acinetobacter spp. in a Brazilian Teaching Hospital, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

The Emergence of Metallo-Beta-Lactamases (MBL) and Increasing Carbapenem Resistance Among P. aeruginosa (PSA) and Acinetobacter spp. (ASP) from Bloodstream Infections (BSI): Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Changing Susceptibility Patterns Among Escherichia coli in Latin America: 6-Year Report of the SENTRY Antimicrobial Surveillance Program, Lead author: Andrade SS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

First Annual Report from the Worldwide ZAAPS Oxazolidinone Resistance and Usage Surveillance Program (2002), Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Resistances in Aeromonas Species from the SENTRY Global Surveillance Program, 1997-2001, Lead author: Turnidge JD, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Evolution and Dissemination of Extended-Spectrum Beta-Lactamase-Producing K. pneumoniae (ESBL+KPN): Epidemiology and Molecular Report from the SENTRY Antimicrobial Surveillance Program During 1997-2003, Lead author: Biedenbach DJ, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

First Description of CTX-M Beta-Lactamase-Producing Klebsiella pneumoniae in Brazil, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

High Rates of Macrolide Resistance and Emerging Quinolone Resistance inStreptococcus agalactiae in the Asia-Pacific Region, Lead author: Turnidge JD, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Recent Declines in Beta-Lactam and MLS_B Resistances Among S. pneumoniae and Age-Related Effects: Report from the SENTRY Antimicrobial Surveillance Program (North America [NA], 1997 – 2002), Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Penicillin and Macrolides Resistance Trends among Streptococcus pneumoniae Isolated in Latin America between 1998 and 2002: Report of SENTRY Antimicrobial Surveillance Program, Lead author: Andrade SS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

In Vitro Activity of Garenoxacin, a Novel Des-F(6)-Quinolone, Against 120,088 Clinical Isolates Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (1999-2002), Lead author: Sader HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Activity of AZD2563 and Comparator Agents Tested Against 6,444 Staphylococci, Streptococci and Enterococci (North America, 2001 – 2002), Lead author: Fritsche TR, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

In Vitro Activity of the Tigecycline, a New Glycylcycline, Tested against 1,326 Clinical Bacterial Strains Isolated from the Latin American Region, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Enhanced Activity of Sitafloxacin against a Large Collection of Gram-positive Isolates From Latin America, Lead author: Andrade SS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

In Vitro Activity of Omiganan (OMI) Pentahydrochloride, a Topical Cationic Peptide, Tested Against Contemporary Bacteria and Yeast Isolates, Lead author: Sader HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Contemporary In Vitro Synergy Rates for Aztreonam Combined with Newer Fluoroquinolones (FQ) and Beta-Lactams Tested Against Gram-Negative Bacilli, Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Worldwide Assessment of Dalbavancin (BI397) Activity and Spectrum (2002), Lead author: Stephen J, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Doripenem (S-4661), A Novel Carbapenem: Comparative Activity Against Contemporary Pathogens Including Anaerobes, Bactericidal Action and Methods Evaluations, Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Doripenem (S-4661), Antimicrobial Activity Tested Against Drug-Resistant Pathogens, Lead author: Huynh H, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

LB11058, a Novel Cephalosporin, Tested Against Neisseria gonorrhoeae Including Drug-Resistant Pathogens, Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Antimicrobial Activity of LB11058, A Novel Cephalosporin, Tested Against Staphylococci, Streptococci and Enterococci, Lead author: Sader HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Antimicrobial Activity of LB11058 Tested Against S. pneumoniae, H. influenzae and M. catarrhalis, Lead author: Johnson DM, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Relationship Between Increased Levofloxacin (LEV) Use and Decreased Susceptibility of Streptococcus pneumoniae (SP): Report From the ARREST Program, Lead author: Bhavnani SM, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Risk Assessment of Macrolide Use in Fed Cattle on the Treatment of Human Food-borne Illness, Lead author: Hurd HS, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Experience with ESBL-Producing Enterobacteriaceae (ENT) Treated with Carbapenems Compared to Other Beta-Lactams: Outcomes Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Jones RN, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

The Emergence of the Extended-Spectrum Beta-Lactamase GES-1 in a Pseudomonas aeruginosa strain in Brazil: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Gales AC, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

In Vitro Susceptibilities of Bloodstream Isolates of Rare Candida Species Against Ravuconazole and Three Licensed Antifungal Agents, Lead author: Pfaller MA, presented at 43rd annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 14 – 17, 2003, Chicago, Illinois

Antimicrobial Susceptibility Patterns for Pathogens Isolated from Pneumonia Patients in Latin American Medical Centers: Analysis from Five Years of the SENTRY Antimicrobial Surveillance Program, Lead author: Gales AC, presented at 103rd annual American Society for Microbiology General Meeting (ASM), May 18 – 22, 2003, Washington, DC

Re-Evaluations of the NCCLS Quality Control (QC) Guidelines for Gatifloxacin and Garenoxacin (BMS284756) When Susceptibility Testing H. influenzae and S. Pneumoniae, Lead author: Biedenbach DJ, presented at 103rd annual American Society for Microbiology General Meeting (ASM), May 18 – 22, 2003, Washington, DC

Initial Quality Control Guidelines for MIC Susceptibility Testing for NVP-LBM415, A Novel Peptide Deformylase Inhibitor, Lead author: Anderegg T, presented at 103rd annual American Society for Microbiology General Meeting (ASM), May 18 – 22, 2003, Washington, DC

Multicenter Quality Control Evaluation Results for Dalbavancin (BI397), An Investigational Glycopeptide With Potent Gram-Positive Activity, Lead author: Rhomberg PR, presented at 103rd annual American Society for Microbiology General Meeting (ASM), May 18 – 22, 2003, Washington, DC

Activity of Mupirocin Tested Against Staphylococci Isolated in Latin American Medical Centers: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 103rd annual American Society for Microbiology General Meeting (ASM), May 18 – 22, 2003, Washington, DC

Antimicrobial Susceptibility of Bacteria Isolated from Blood Stream Infections (BSI) in Two Argentinean Medical Centers: Results from the SENTRY Antimicrobial Surveillance Program (1997-2001), Lead author: Smayevsky J, presented at 103rd annual American Society for Microbiology General Meeting (ASM), May 18 – 22, 2003, Washington, DC

Antagonism (ANTAG) Between Penicillin and Erythromycin Against Streptococcus pneumoniae: Does It Exist?, Lead author: Jones RN, presented at 103rd annual American Society for Microbiology General Meeting (ASM), May 18 – 22, 2003, Washington, DC

Clonal Dissemination and Expansion of Extended Spectrum beta-Lactamase (ESBL) Producing K. Pneumoniae in a Large Metropolitan Teaching Hospital: An Epidemiologic History from the SENTRY Antimicrobial Surveillance Program, Lead author: Dipersio J, presented at 103rd annual American Society for Microbiology General Meeting (ASM), May 18 – 22, 2003, Washington, DC

VIM-1 or VIM-1 + VIM-2 metallo-lactamase-producing Pseudomonas aeruginosa isolated from hospitalized children in Poland (1997-2002), Lead author: Patzer J, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Epidemiology and frequency of antimicrobial resistances among pathogens causing surgical site infections: Report from the SENTRY Antimicrobial Surveillance Program in United States, Canada, and Europe, Lead author: Mathai D, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Characterization of antimicrobial susceptibility patterns among community-acquired isolates of beta-haemolytic streptococci in Latin America: Results from the SENTRY Antimicrobial Surveillance Program (2001), Lead author: Gales AC, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Contemporary activity of grepafloxacin: Re-evaluation of antimicrobial features of a potent fluoroquinolone, Lead author: Jones RN, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Comparative activity of Garenoxacin against ciprofloxacin-susceptible and resistant Streptococcus pneumoniae isolates: Report from the SENTRY Antimicrobial Surveillance Programm (Europe, 1999-2001), Lead author: Canton R, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Initial description of the L22 mutation responsible for quinupristin/dalfopristin resistance in Streptococcus pneumoniae: Case Reports from the SENTRY Antimicrobial Surveillance Program, Lead author: Jones RN, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Cloning of a hybrid metallo-beta-lactamase gene conferring a novel IMP variant blaIMP-13 in Pseudomonas aeruginosa in Italy: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Toleman MA, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Species distribution and antifungal susceptibility patterns for Candida isolates from the SENTRY Antimicrobial Surveillance Program (Europe), Lead author: Prodhom G, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Prevalence and resistance rates of Enterobacter spp. in nosocomial infections, Euro-SENTRY Antimicrobial Surveillance program, 1997-2001, Lead author: Rodriguez-Villalobos H, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Evolution of an integron carrying blaVIM-2 in Central Europe: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Toleman MA, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Epidemiology of the new metallo-beta-lactamase gene, blaSPM, in South America: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Toleman MA, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland

Analysis of the blaVIM gene context from Italy reveals novel resistant cassettes: Report from the SENTRY Antimicrobial Surveillance Program, Lead author: Toleman MA, presented at 13th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), May 10 – 13, 2003, Glasgow, Scotland